Towards a Strategy for High Density Cultures of Vero Cells in Stirred Tank Reactors

  • R. X. van der Meer
  • M. C. Philippi
  • B. Romein
  • C. A. M. van der Velden-de Groot
  • E. C. Beuvery
Chapter
Part of the Animal Cell Technology: Basic & Applied Aspects book series (ANICELLTECH, volume 5)

Abstract

Results from batch and continuous perfusion cultivations of Vero-cells are presented. Using standard medium, highest cell densities were reached by continuous perfusion, whereas cell yield per unit of medium was highest in batch cultivation. Amino acid consumption-and production patterns were in both systems comparable, except for alanine. Alanine was produced during continuous perfusion and slightly consumed during batch cultivation. Results from measurement and control equipment can be used to calculate cell density on-line. Image analysis can be employed to analyse cell distribution over microcarriers.

Keywords

Batch Cultivation Vero Cell Cell Yield Stir Tank Reactor Medium Utilization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Glacken M.W., Fleischaker R.J. and Sinskey A.J. (1986) ‘Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells’, Biotechnology & Bioengineering XXVIII, 1376–1389CrossRefGoogle Scholar
  2. [2]
    Miller W.M., Wilke C.R. and Blanch H.W. (1989) ‘Transient responses of hybridoma cells to nutrient additions in continuous culture: I. glucose pulse and step changes’ Biotechnology & Bioengineering 33, 477–486CrossRefGoogle Scholar
  3. [3]
    Eagle H. (1959) ‘Amino acid metabolism in mammalian cell cultures’, Science 159, 432–437CrossRefGoogle Scholar
  4. [4]
    Wieten et al. G. (1989) ‘The CF 1000: second generation instrumentation for monitoring and control of bioreactors’ in R.E. Spier, J.B. Griffiths, J. Stephenne and P.J. Crooy (eds.), Advances in animal cell biology and technology for bioprocesses, Butterworth & Co. Ltd., Sevenoaks, 408–411Google Scholar
  5. [5]
    Kempken R., Büntemeyer H. and Lehmann J. (1991) ‘The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system’ Cytotechnology 7, 63–74PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1993

Authors and Affiliations

  • R. X. van der Meer
    • 1
  • M. C. Philippi
    • 1
  • B. Romein
    • 2
  • C. A. M. van der Velden-de Groot
    • 1
  • E. C. Beuvery
    • 1
  1. 1.National Institute for Public Health and Environmental Protection (RIVM)BilthovenThe Netherlands
  2. 2.Department of Biochemical EngineeringDelft University of Technology, project group controlDelftThe Netherlands

Personalised recommendations